Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019;17(1):40-46.
doi: 10.2174/1871525717666190524092918.

Radioprotective Effect of Gliclazide as an Anti-Hyperglycemic Agent Against Genotoxicity Induced by Ionizing Radiation on Human Lymphocytes

Affiliations

Radioprotective Effect of Gliclazide as an Anti-Hyperglycemic Agent Against Genotoxicity Induced by Ionizing Radiation on Human Lymphocytes

Maysa Pouri et al. Cardiovasc Hematol Agents Med Chem. 2019.

Abstract

Objectives: Gliclazide (GL) is widely used to reduce hyperglycemia in diabetic patients. The aim of this study was to investigate the protective effect of GL against chromosome damage induced by ionizing radiation in human blood lymphocytes.

Methods: In this experimental study, peripheral blood samples were collected from human volunteers and treated with GL at various concentrations (5, 25, 50 or 100 μM) for three hours. Then samples were irradiated to X-ray (1.5 Gy). Blood samples were cultured with mitogenic stimulation. The frequencies of micronuclei in cytokinesis-blocked binucleated lymphocytes were determined in the different samples. The antioxidant activities of GL were assayed by two different methods as 1,1- diphenyl-2-picryl hydrazyl radical (DPPH) free radical scavenging and reducing antioxidant power assays.

Results: GL significantly reduced the percentage of micronuclei in lymphocytes which were irradiated. The maximum radioprotection in the reduction of percentage of micronuclei in lymphocytes was observed at 100 μM of GL with 52% efficacy. GL exhibited excellent free radical scavenging activity and reducing power at concentration dependent activities. The IC50 values of GL were lower than ascorbic acid. Higher potencies were observed in the antioxidant activities for GL than ascorbic acid in both methods.

Conclusion: This data exhibits that GL is a powerful radioprotective agent that could protect healthy cells against the chromosome damage induced by ionizing radiation through antioxidant activity. The radioprotective effect is new indication of GL for patient's protection against side effect induced by ionizing radiation.

Keywords: DNA; genotoxicity; gliclazide; ionizing radiation; radioprotective; reactive oxygen species..

PubMed Disclaimer

Figures

Fig. (1)
Fig. (1)
A typical binucleated lymphocyte with micronucleus in this study.
Fig. (2)
Fig. (2)
Free radical scavenging effect of different concentrations of gliclazide and ascorbic acid on the 1,1-diphenyl-2-picrylhydrazyl (DPPH) free radical at 517 nm.
Fig. (3)
Fig. (3)
Reducing power of different concentrations of gliclazide and ascorbic acid with ferric reducing power system.

Similar articles

Cited by

References

    1. Hosseinimehr S.J. Flavonoids and genomic instability induced by ionizing radiation. Drug Discov. Today. 2010;15(21-22):907–918. - PubMed
    1. Sage E., Shikazono N. Radiation-induced clustered DNA lesions: Repair and mutagenesis. Free Radic. Biol. Med. 2017;107:125–135. - PubMed
    1. Smith T.A., Kirkpatrick D.R., Smith S., Smith T.K., Pearson T., Kailasam A., Herrmann K.Z., Schubert J., Agrawal D.K. Radioprotective agents to prevent cellular damage due to ionizing radiation. J. Transl. Med. 2017;15(1):232. - PMC - PubMed
    1. Hosseinimehr S.J. Trends in the development of radioprotective agents. Drug Discov. Today. 2007;12(19-20):794–805. - PubMed
    1. Hosseinimehr S.J., Mahmoudzadeh A., Ahmadi A., Ashrafi S.A., Shafaghati N., Hedayati N. The radioprotective effect of Zataria multiflora against genotoxicity induced by γ irradiation in human blood lymphocytes. Cancer Biother. Radiopharm. 2011;26(3):325–329. - PubMed

MeSH terms